ChemoCentryx
CCXI
#3611
Rank
NZ$6.31 B
Marketcap
NZ$87.85
Share price
0.00%
Change (1 day)
26.83%
Change (1 year)

Market capitalization of ChemoCentryx (CCXI)

Last known market cap: NZ$6.31 Billion

On November 25, 2022 ChemoCentryx had a market cap of NZ$6.31 Billion. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of ChemoCentryx from 2012 to 2022

End of year Market Cap

Year Marketcap Change
2022NZ$5.88 B57.76%
2021NZ$3.73 B-37.15%
2020NZ$5.93 B67.9%
2019NZ$3.53 B329.36%
2018NZ$0.82 B101.65%
2017NZ$0.40 B-20%
2016NZ$0.51 B-2.34%
2015NZ$0.52 B38.08%
2014NZ$0.37 B25.33%
2013NZ$0.30 B-37.5%
2012NZ$0.48 B

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
NZ$1.004 T 15,803.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$255.35 B 3,941.77%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
NZ$698.69 B 10,958.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$343.39 B 5,335.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
NZ$45.63 B 622.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$500.60 B 7,823.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$210.65 B 3,234.30%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$194.87 B 2,984.46%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
NZ$63.52 B 905.44%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel